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The presence of macrophages in inflamed glomeruli
of rat kidney correlates with proliferation and apo-
ptosis of resident glomerular mesangial cells. We as-
sessed the contribution of inflammatory macro-
phages to progressive renal injury in murine
crescentic glomerulonephritis (GN). Using a novel
transgenic mouse (CD11b-DTR) in which tissue mac-
rophages can be specifically and selectively ablated
by minute injections of diphtheria toxin, we depleted
renal inflammatory macrophages through days 15
and 20 of progressive crescentic GN. Macrophage de-
pletion reduced the number of glomerular crescents,
improved renal function, and reduced proteinuria.
Morphometric analysis of renal tubules and intersti-
tium revealed a marked attenuation of tubular injury
that was associated with reduced proliferation and
apoptosis of tubular cells. The population of intersti-
tial myofibroblasts decreased after macrophage de-
pletion and interstitial fibrosis also decreased. In the
presence of macrophages, interstitial myofibroblasts
exhibited increased levels of both proliferation and
apoptosis, suggesting that macrophages act to sup-
port a population of renal myofibroblasts in a high
turnover state and in matrix deposition. Finally, de-
letion of macrophages reduced CD4 T cells in the
diseased kidney. This study demonstrates that macro-
phages are key effectors of disease progression in
crescentic GN, acting to regulate parenchymal cell
populations by modulating both cell proliferation
and apoptosis. (Am J Pathol 2005, 167:1207–1219)
The biology of macrophages in different tissue settings
has been of broad scientific interest, at least in part
because of the pleiotropic functions ascribed to mac-
rophages. We have previously demonstrated that dur-
ing development of the rodent eye, macrophages are
responsible for deletion of capillary endothelial cells
through induction of endothelial cell apoptosis.1–3 This
function of macrophages has been recapitulated in ex
vivo modeling of inflammation in which activated in-
flammatory macrophages have been found to induce
apoptosis of glomerular mesangial cells of the kid-
ney.4,5 In other model systems of inflammation, mac-
rophages have the capacity to induce apoptotic cell
death of epithelial cells during inflammation.6–8 In fact,
although macrophages are characterized by their ca-
pacity to phagocytose particles, phagocytes in the
developing worm and fly also play a crucial role in
active deletion of effete cells, in addition to phagocytic
clearance, indicating that macrophage-directed killing
of cells is common to all metazoans.9–12 Rather con-
fusingly, although macrophages have the capacity to
induce apoptosis of parenchymal cells in inflammation
and organ development, model systems of macro-
phages also indicate that they may induce proliferation
of parenchymal cells.6,13 Indeed, we have previously
shown that the presence of macrophages in the in-
flamed glomerulus of the rat kidney is correlated with
both proliferation and apoptosis of resident glomerular
mesangial cells.6,14
When macrophages are cultured with fibroblasts/
myofibroblasts, the net result is either deposition of
matrix components, or lytic degradation of matrix, de-
pending on the activation state of the macro-
phage.15,16 These data suggest macrophages also
play a role in the deposition of fibrous tissue, which so
frequently heralds inflammatory scarring and organ
Supported by the National Kidney Research Fund, UK (senior fellowship
to J.S.D.), the Wellcome Trust (senior fellowship in clinical science grant
061139 to J.H.), and the National Institutes of Health (grants DK39773 and
DK38452 to J.V.B.).
Accepted for publication July 19, 2005.
Address reprint requests to Jeremy S. Duffield, Renal Division, Brigham
& Women’s Hospital, Harvard Institutes of Medicine, 5th Floor, 77 Avenue
Louis Pasteur, Boston MA 02115. E-mail: jduffield@rics.bwh.harvard.edu.
American Journal of Pathology, Vol. 167, No. 5, November 2005
Copyright © American Society for Investigative Pathology
1207
dysfunction. In addition when activated macrophages
are cultured with mesangial cells from the kidney, a cell
with myofibroblast characteristics, the macrophages
exhibit a cell-cycle-dependent killing by apoptosis of
the mesangial cells, thereby showing the capacity to
regulate survival of neighboring, scar-producing myo-
fibroblast cells.4 Further evidence for a role for inflam-
matory macrophages in the development of scarring
can be seen in skin wounding because wounds under-
going repair occurring in the absence of macrophages
exhibit no scarring.17
Macrophages have been studied previously using var-
ious methods to effect depletion including mustine hydro-
chloride, anti-macrophage serum, and more recently li-
posomal clodronate.18–21 Many early studies pointed to
macrophage involvement in disease initiation whereas
few studied macrophages in disease progression.22 Fur-
thermore, many methods for depletion were not macro-
phage-specific, were highly toxic, were ineffective in
some tissues or simultaneously depleted neutrophils,
thereby sometimes rendering interpretation of the results
difficult.23
We recently generated a transgenic mouse (CD11b-
DTR) in which macrophages specifically express the hu-
man diphtheria toxin receptor (DTR) such that macro-
phages can be specifically ablated by a simple
intravenous injection of diphtheria toxin (DT).24,25 Mice
are normally resistant to DT as the murine DTR binds DT
poorly. Using this powerful new tool we have shown that
inflammatory macrophages can be specifically depleted
from solid organs and have begun to examine their bio-
logical effects in vivo.24
To understand the functions of macrophages in inflam-
mation further, we ablated macrophages during a well-
described model of progressive inflammatory injury in the
kidney. The single injection of nephrotoxic serum into
mice induces a crescentic glomerulonephritis (GN) that
progresses throughout 4 weeks to organ failure and is
analogous to human crescentic GN. It is characterized by
inflammatory disease of the renal glomerulus resulting in
characteristic crescents together with marked inflamma-
tory macrophage infiltration. As disease progresses, in-
flammatory destruction of the whole nephron, interstitial
scarring, organ failure, and death ensues. Although the
importance of macrophages in disease initiation has
been previously studied in this model,26 the function of
macrophages in progression of established disease re-
mains unexplored. Furthermore, for the first time our
transgenic mouse model allows highly selective ablation
of macrophages.
Here we demonstrate macrophages are necessary for
disease progression. Detailed tissue analysis indicates
that inflammatory macrophages in the kidney induce both
cell death and proliferation of tubular epithelial cell and
interstitial myofibroblast populations. The outcome of per-
sistent macrophage infiltration is progressive injury and
loss of epithelial cells, and through maintenance of the
population of interstitial myofibroblasts, the development
of interstitial fibrosis.
Materials and Methods
Animals
CD11b-DTR mice were generated and characterized as
previously described.24,25 These mice are transgenic for
the human diphtheria toxin (DT) receptor (DTR) under the
control of the CD11b promoter. The murine DT receptor
binds DT poorly such that expression of the human re-
ceptor confers toxin sensitivity. Administration of minute
(ng) doses of DT results in rapid and marked macro-
phage ablation in the peritoneum, kidney, and ovary and
does not affect murine neutrophil populations.24,25 Strain
match controls (FVB/N) were purchased from B and K
Ltd., Hull, UK. Animals were maintained in a standard
barrier facility and had free access to chow and water. All
experiments were performed in accordance with Home
Office (UK) guidelines.
Disease Model
Nephrotoxic serum was prepared by serial inoculation of
sheep with crude insoluble protein fraction of mouse
cortex as previously described.26 In preliminary studies
10- to 14-week-old, 28 to 30 g, CD11b-DTR male mice
were injected intravenously with 200 to 600 l of nephro-
toxic serum, divided in two doses 2 hours apart, to as-
sess disease severity and progression. The 400-l dose
of nephrotoxic serum induced autologous proteinuric ne-
phritis in all animals with 40% glomerular crescents at
21 days. This regimen was selected for further study.
Disease was induced in cohorts of 10- to 14-week-old
male CD11b-DTR mice and dipstick proteinuria carefully
monitored. At 15 days all mice with 3 to 4 proteinuria
but without ascites were randomly assigned to macro-
phage depletion (DT) or control [phosphate-buffered sa-
line (PBS)] injections (n  11 per group). DT (10 ng/g
body weight) or an equal volume of PBS was injected
intravenously on days 15, 17, and 19 with tissue being
harvested 24 hours later on day 20. To be sure that the
groups were comparable we retrospectively assessed
urine collected at 15 days in more detail. At day 15 the
group assigned to DT had 145 33 mg/L proteinuria with
a Uprot/Cr ratio of 5.2  1.1. The group assigned to PBS
treatment had 114  53 mg/L proteinuria with a Uprot/Cr
of 3.2  0.9. There were no statistical differences be-
tween the two groups. A small group of mice (n 3) from
each cohort had tissue harvested on day 15 before mac-
rophage depletion while a further cohort (n  3) of ne-
phritic FVB/N wild-type mice completed the DT macro-
phage depletion regimen in parallel with CD11b-DTR
mice. Two hours before harvesting of organs, bromode-
oxyuridine (BrdU) (Boehringer Mannheim) (50 g/g) was
injected intraperitoneally.
Assessment of Disease
Urine was collected on day 15 and day 20, and protein
and creatinine levels determined by the Bradford assay
and picric acid method (Beckman Analyzer II), respec-
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tively. Blood was collected (day 20) by cardiac puncture
and creatinine concentration determined. Kidneys and
spleen were harvested at day 20 and tissue was fixed in
methyl Carnoy’s solution (60% methanol, 30% chloro-
form, and 10% glacial acetic acid), 10% neutral buffered
formalin, or 2% paraformaldehyde, lysine, periodate
(PLP) fixative.26 The number of glomerular crescents,
glomerular thrombonecrotic lesions, and tubulointerstitial
disease was determined by blinded analysis of periodic
acid-Schiff-stained formalin-fixed 3-m sections using
established scoring methods.26 A semiquantitative tubu-
lar atrophy score was adapted from assessment of hu-
man biopsies:27 0, absence of atrophy; 1, atrophy in
25% of biopsy; 2, involving 25 to 50% of biopsy; and
3, involvement of 50% of the biopsy. In addition, 10
serial cortical images (magnification 200) were digitally
captured covering the whole cortex. The area of cortex
occupied by tubular luminal space, a marker of tubulo-
interstitial disease,28,29 was measured by quantitative
morphometric analysis using image analysis software
(Fovea Pro, Reindeer Graphics).24,28 PLP-fixed, cryo-
tome 5-m sections were immunostained for macro-
phages using anti-CD68 antibody (Serotec, Oxford, UK)
as described previously.30 CD68 was selected over other
macrophage markers because not all inflammatory mac-
rophages in the murine glomerulus express other macro-
phage-specific markers such as F4/80.30 The area of
cortex occupied by macrophages was assessed by mor-
phometric analysis of serially captured images (200) of
the whole cortex. In addition, the number of intraglomeru-
lar macrophages was counted in 50 sequentially ob-
served glomeruli.30 Sections were labeled with anti-CD4
or anti-CD8 antibodies (1:200) (eBioscience, San Diego,
CA) in PBS containing rabbit and mouse serum. Specific
labeling was detected using biotinylated anti-rat IgG and
the ABC peroxidase system followed by incubation of
sections with diaminobenzidine (DAKO, Carpinteria, CA).
T cells were assessed in glomeruli as described for
CD68-positive cells. Interstitial T cells were assessed by
counting the number per high-power field (HPF). At least
50 HPFs were assessed serially covering the whole cor-
tex in sagittal kidney sections, and data presented as T
cells/HPF. Collagen III and -smooth muscle actin (-
SMA) immunostaining was performed on methyl Car-
noy’s-fixed sections as previously described.31 The area
of collagen III deposition and -SMA staining in tissue
sections was assessed using the morphometric methods
described above. Area of stain was expressed as a pro-
portion of total cortical area. The number of -SMA cells
in glomerular crescents of 50 consecutive glomeruli was
assessed (observer blinded) using the following scoring
method: 0, no cells; 1, occasional periglomerular cells; 2,
many but discontinuous cells; 3, a continuous layer of
positive cells surrounding the glomerulus; 4, in addition to
3, multiple layers of positive cells.
Formalin-fixed sections were stained for BrdU incorpo-
ration using established antigen retrieval methods24 and
anti-BrdU antibody (Serotec). In addition, sections were
stained for proliferating cell nuclear antigen (PCNA), an-
other marker of proliferation, using anti-PCNA antibody
(DAKO) as previously described.32 To assess apoptosis,
formalin-fixed sections were prepared for the terminal
dUTP nick-end labeling (TUNEL) reaction and immuno-
stained with diaminobenzidine using preprepared com-
ponents (Oncor, Gaithersburg, MD).14 BrdU- and PCNA-
positive cells were counted within the glomeruli (50 per
mouse), crescents (50 per mouse), tubules and intersti-
tium (50 HPF per mouse). TUNEL-positive cells were
counted similarly, but in addition to positive nuclear stain,
the nucleus was required to exhibit morphological char-
acteristics of apoptosis.14 For quantification of proliferat-
ing interstitial macrophages, Methyl Carnoy’s-fixed, 3-m
sections were initially immunostained with anti-F4/80 an-
tibodies (Caltag, Burlingame, CA) using peroxidase-cat-
alyzed diaminobenzidine stain.24 Stained sections were
acid-treated to retrieve nuclear antigens, then labeled
with fluorescein isothiocyanate-conjugated anti-BrdU an-
tibodies in the presence of Fc-block (Pharmingen, La
Jolla, CA). Sections were viewed by bright field and by
epifluorescence and combined (fluorescent and bright
field) serial cortical images were scored positive if an
interstitial nucleus was surrounded by F4/80 staining.
Peripheral blood leukocytes were prepared, immuno-
labeled, and assessed by flow cytometry as previously
described.25 Leukocytes were immunolabeled for neutro-
phils (anti-Gr-1-PE; eBioscience), monocytes (anti-
CD11b-fluorescein isothiocyanate, eBioscience; and an-
ti-F4/80-APC, Caltag), and T cells (anti-CD3-fluorescein
isothiocyanate, Pharmingen). Monocytes were assessed
as F4/80-positive or CD11b-positive, Gr-1-negative.
Real-Time Reverse Transcriptase-Polymerase
Chain Reaction (PCR)
RNA was purified from nephritic kidneys and cDNA pre-
pared as previously described.24 cDNA was analyzed for
content using a SYBR green-based, quantitative fluores-
cent PCR method (Qiagen, Valencia, CA). Fluorescence
was detected with the iCycler system (Bio-Rad, Hercules,
CA). The following primer pairs were used for detection
of specific cDNAs: GAPDH, 5-CTGAGAAACCTGC-
CAAGTA-3 and 5-AAGAGTGGGAGTTGCTGTTG-3;
tumor necrosis factor-, 5-CGCTCTTCTGTCTACTG
AACTT-3 and 5-GATGAGAGGGAGGCCATT-3; inter-
leukin-10, 5-CAGCCTTGCA GAAAAGAGAG-3 and 5-
GGAAGTGGGTGCAGTTATTG-3; transforming growth
factor-1, 5-CTCCACCTGCAAGACCAT-3 and 5-CT-
TAGTTTGGACAGGATCTGG-3; matrix metalloprotein-
ase (MMP)-13, 5-TAAGGCAGAAATATTATGTAGAA-3
and 5-AAAGCAGAGAGGG ATTAACAA-3; tissue inhib-
itor of matrix metalloproteinase (TIMP)-1, 5-TTCCAGTA-
AGGCCTGTAG C-3 and 5-TTATGA CCAGGTC-
CGAGTT-3. Each assay was performed in duplicate in a
25-l reaction volume comprising 2 SYBR green mas-
termix, 0.5 l of cDNA with primers included at 300
nmol/L. The following PCR conditions were used: 95°C for
15 minutes, followed by 45 cycles of 94°C for 15 sec-
onds, 50°C for 30 seconds, 72°C for 30 seconds, fol-
lowed by 72°C for a final 10 minutes. Each PCR reaction
was also tested to assure a single product of the pre-
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dicted size. Quantification of each PCR product was
expressed relative to GAPDH.
Statistics
Continuous variables are expressed as mean  SEM.
Discontinuous variables as mean  95% CI. Differences
among groups were assessed by analysis of variance
and between groups assessed by Mann Whitney rank-
sum test.
Results
Administration of Diphtheria Toxin Induces
Conditional Macrophage Ablation in Advanced
Crescentic GN
To determine the effects of macrophages on progressive
disease we depleted macrophages for a period of 5 days
during established crescentic GN between day 15 and
day 20. Immunostaining of day 20 renal tissue for mac-
rophages confirmed marked depletion of glomerular
macrophages (Figure 1, A and C) and a 50% reduction in
whole cortical staining for CD68 (Figure 1, A and B). In
addition, the administration of DT to diseased strain-
matched control mice had no effect on glomerular or
interstitial macrophage infiltration confirming the specific-
ity of macrophage ablation in this model of renal inflam-
mation (Figure 1, B and C). We have previously demon-
strated absence of the resident macrophage population
in the normal kidneys of DTR mice 24 hours after intra-
peritoneal administration of DT.25 Intravenous injection of
10 ng/g of DT into healthy DTR mice lead to a 97.4 
2.1% reduction in CD68 resident kidney macrophages
24 hours after the injection. Similar injection of DT led to
an 87.4  14.9% reduction in circulating monocytes (see
Table 2 for details). It is therefore likely that the reduction
in kidney macrophages during crescentic GN reflects a
reduction in both resident and infiltrating populations of
cells.
Macrophage Depletion Reduces Histological
Injury
Macrophage depletion resulted in a striking and signifi-
cant reduction in the number of cellular glomerular cres-
cents (Figure 2, A and B). Glomerular crescents are
associated with severe glomerular disease and signify
poor outcome in many human studies. The proportion of
glomeruli exhibiting focal areas of necrosis was also re-
duced after macrophage depletion but this was not sig-
nificantly different (Figure 2, A and C). In addition to
histological changes in the glomerulus, macrophage de-
pletion resulted in a significant reduction in injury to ep-
Figure 1. Diphtheria toxin successfully depletes glomerular and interstitial macrophages during nephrotoxic nephritis in the CD11b-DTR mouse. A: CD68
immunostaining of tissue sections from mice at 20 days after three doses of diphtheria toxin (DT) commencing at day 15 (right) or control treatment (left). Note
areas of intense macrophage infiltration (arrows). Interstitial, crescentic, and intraglomerular macrophages are depleted. B: Morphometric analysis of the whole
cortical area indicates that DT significantly reduces the area of tissue occupied by macrophages compared with PBS-treated diseased mice. Note, strain-matched,
control diseased mice exhibit an interstitial macrophage infiltrate comparable to PBS-treated CD11b-DTR mice (**P  0.01). C: The number of intraglomerular
macrophages is significantly reduced after DT administration in the CD11b DTR mice compared with PBS-treated diseased mice and strain-matched controls (**P
0.01).
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ithelial tubules and reduction in interstitial disease. In
macrophage-depleted mice, semiquantitative assess-
ment of tubular injury using a tubular atrophy score (0 to
3) showed tubular atrophy to be reduced (2.4  0.7
versus 1.1  0.6; PBS versus DT treatment).27 The de-
gree of tubular injury was also assessed by quantifying
tubular luminal space using computerized morphometric
analysis expressed as a proportion of the area of the
whole cortex.28,31 Morphometric measurement of tubular
luminal space, resultant on tubular dilatation and flatten-
ing of injured dedifferentiated epithelial cells, is a param-
eter of tubular injury and has recently been shown to be
associated with a poor prognosis in lupus nephritis.28
Using this automated objective method, this parameter of
tubular injury was markedly attenuated in macrophage-
depleted mice (Figure 2, A and D) indicating that infiltrat-
ing interstitial macrophages were important effectors of
progressive tubulointerstitial injury. Importantly, our
model of crescentic GN exhibited progressive histologi-
cal changes during the third week of disease. At day 15
the percentage of glomeruli with crescents was 22  6%
(39  10% at 20 days) and the percentage cortical area
of tubular luminal space was 9.4  2.9% (14  3% at 20
days). By comparison the percentage of glomeruli with
crescents at day 20 in DT-treated mice was 12 6% and
the area of tubular luminal space was 4  1% (Figure
2D). The degree of reduction in crescents and tubular
injury (as assessed by luminal space) might suggest that
not only does macrophage depletion halt histological
progression but may lead to reversal of histological
disease.
Macrophage Depletion Improves Renal Function
This model of crescentic GN is associated with signif-
icant renal failure and plasma protein leak into the urine
(proteinuria). Plasma creatinine level, a measure of
renal dysfunction, was quantified in healthy mice, dis-
eased mice at 15 days, before administration of DT or
PBS, and at 20 days after macrophage depletion (Fig-
ure 3A). Compared with healthy mice, plasma creati-
nine was elevated in diseased mice at 15 days. At 20
days, the creatinine level remained elevated in both
control diseased mice and DT-treated diseased mice.
The macrophage-depleted diseased mice, however,
exhibited less severe renal impairment. In addition, the
degree of proteinuria expressed as the protein/Cr ratio
was increased in diseased mice at day 15, compared
with healthy mice. Although not reaching statistical
significance, DT-treated mice at day 20 exhibited a
reduced protein/Cr ratio compared with control dis-
Figure 2. Histological parameters of renal injury are reduced after conditional macrophage
ablation. A: Periodic acid-Schiff-stained sections (600) from mice at day 20 after three
doses of diphtheria toxin (DT) commencing at day 15 (right) or control PBS treatment
(left). Glomerular crescents are reduced and tubulointerstitial injury is ameliorated. B:
Quantification of the percentage of glomeruli with crescents in DT-treated and PBS-treated
diseased CD11b-DTR mice at day 20 (**P  0.01). C: Quantification of the percentage of
glomeruli with necrotic lesions in DT-treated or PBS-treated diseased CD11b-DTR mice. D:
Quantitative morphometry of the area of tubular space in the cortex in DT-treated and
PBS-treated diseased CD11b-DTR mice (**P  0.01).
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eased mice in keeping with reduced glomerular injury
(Figure 3B). Furthermore, between day 15 and day 20
the protein/Cr ratio increased significantly in the con-
trol diseased mice whereas in DT-treated mice the
protein/Cr ratio did not rise.
Macrophage Depletion Reduces Interstitial and
Crescent Myofibroblasts
We assessed periglomerular (crescent) and interstitial
myofibroblasts because these cells are strongly impli-
cated in crescent generation and the development of
interstitial fibrosis.33,34 Sections were immunostained for
the cytoskeletal protein -SMA expressed selectively by
these myofibroblasts (Figure 4A) and the area of cortex
occupied by -SMA staining was assessed morphometri-
cally as an indirect measure of the interstitial myofibro-
blast population. This analysis indicated that the popula-
tion of interstitial myofibroblasts was significantly
reduced after macrophage depletion (Figure 4C). In ad-
dition, using blinded, semiquantitative scoring of the peri-
glomerular regions for the presence of myofibroblasts,
macrophage depletion during disease resulted in a di-
minished population of periglomerular myofibroblasts
that occupy the crescent (Figure 4B). These results sug-
gest that macrophages are responsible for maintaining a
population of myofibroblasts that are believed to be re-
sponsible for matrix deposition and fibrosis. To exclude
the possibility that the loss of fibroblasts was due to death
induced by DT, cultured bone marrow-derived macro-
phages and cultured embryonic fibroblasts from DTR
mice were treated with DT. Cell viability was assessed by
the reduction of MTT [3-(4,5-dimethyl thiazol-2-yl)-2,5-
diphenyl tetrazolium bromide] to formazan dye by live
cells. After 4 hours of exposure to DT bone marrow-
derived macrophages lost viability at a dose of DT of 10
pg/ml whereas loss of viability of fibroblasts occurred at a
dose 105 pg/ml (data not shown). This indicates that the
loss of fibroblasts in the kidneys of DT-treated mice is
secondary to macrophage depletion.
Macrophage Depletion Reduces Interstitial
Deposition of Collagen III
Collagen III is a representative collagen of the injured and
scarred renal interstitium and is deposited by fibroblasts
during pathological disease.35 We stained sections for
collagen III and measured deposition of collagen III ob-
jectively in the renal cortex using morphometric methods.
The area of collagen III in the cortex was significantly
reduced after 5 days of macrophage depletion (Figure 5)
despite the fact that macrophages do not synthesize this
matrix protein. This suggests that macrophages may di-
rect interstitial fibroblasts to synthesize interstitial matrix
either by regulating the balance between synthesis
and degradation of myofibroblast-generated matrix com-
ponents, or regulating the size of the myofibroblast
population.
Macrophage Depletion Modulates Both
Proliferation and Apoptosis within Glomerular
Crescents and the Tubulointerstitium
We have previously reported that macrophages may reg-
ulate glomerular mesangial cell number by inducing
apoptosis and inhibiting mitosis in proliferating cells in
vitro.4,5 In addition, similar findings for apoptosis have
been reported in co-cultures of macrophages and a prox-
imal tubular cell line.7 We therefore hypothesized that
infiltrating renal macrophages may modulate the prolifer-
ation and apoptosis of resident renal cells in vivo during
renal inflammation. Kidney sections were immunolabeled
for markers of both proliferation and apoptosis. Com-
pared with control diseased mice at 20 days, there was a
marked reduction in BrdU-positive nuclei in both the glo-
merulus and the tubulointerstitium (Figure 6). Approxi-
mately half of the BrdU-positive tubulointerstitial cells
were tubular epithelial cells and half were interstitial cells
(Table 1). In both tissue compartments, macrophage de-
pletion resulted in a marked reduction in BrdU positivity.
PCNA staining of tissue sections revealed a very similar
pattern [128  8 (no macrophage depletion), 73  12
(macrophage depletion) in the tubulointerstitium per 50
HPF, and 18  3 (no macrophage depletion), 10  2
(macrophage depletion) in the glomerulus per 50 gcs]. A
significant correlation was evident between the area of
cortical staining for macrophages and the number of
BrdU-staining cells in each mouse (Table 1) thereby sup-
Figure 3. Renal function improves after conditional macrophage ablation. A:
Plasma creatinine in healthy CD11b-DTR mice, diseased mice at 15 days, and
diseased mice at 20 days after PBS treatment or DT treatment. Note significant
reduction in creatinine after macrophage depletion (*P  0.05). B: Urinary
protein to creatinine ratio in healthy CD11b-DTR mice, diseased mice at 15
days, and diseased mice at 20 days after PBS treatment or DT treatment. Note
in the PBS-treated group proteinuria increases significantly from day 15 to
day 20 (*P  0.05) whereas in the DT-treated group proteinuria does not
increase.
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porting a link between macrophage infiltration and paren-
chymal cell proliferation. In addition, macrophage deple-
tion resulted in reduced numbers of BrdU-positive cells in
periglomerular areas (Table 1). It has been reported that
macrophages in the interstitium of diseased kidneys can
themselves proliferate.36,37 To determine the proportion
Figure 4. Crescentic and interstitial myofibroblasts are reduced after macrophage ablation. A: Immunolabeling of crescentic and interstitial -SMA, which is
restricted to myofibroblasts. B: Semiquantitative scoring of crescent fibroblasts. Note a significant reduction in DT-treated CD11b-DTR mice but not in strain
matched (**P  0.01). C: Quantitative morphometry of -SMA-expressing myofibroblasts in the cortical interstitium. Note that myofibroblasts are reduced after
DT treatment in the CD11b-DTR mice but not in strain matched control (**P  0.01).
Figure 5. Interstitial collagen III deposition is reduced after macrophage ablation. A: Immunostaining (100) for collagen III showing interstitial deposition in
diseased mice, which is reduced after macrophage depletion (right). B: Quantitative morphometry of percentage area of cortical collagen III deposition in
PBS-treated and DT-treated diseased CD11b-DTR mice and also strain-matched control DT-treated mice (**P  0.01).
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Figure 6. Glomerular and tubulointerstitial proliferation are reduced by macrophage ablation. A: Immunostaining (600) showing BrdU-positive intraglomerular
cells (arrows), periglomerular cells (arrowheads, top left), and (400) BrdU-positive tubular epithelial and interstitial cells (top right). A reduction in
glomerular (bottom left) and tubulointerstitial (bottom right) BrdU-positive cells is seen after macrophage depletion. B: The number of BrdU-positive cells per
50 glomerular cross sections in PBS-treated and DT-treated diseased CD11b-DTR mice and also strain control DT-treated mice (**P  0.01). C: The number of
BrdU-positive cells per 50 HPF of whole kidney in PBS-treated and DT-treated diseased CD11b-DTR mice and also strain control DT-treated mice (**P  0.01).
Table 1. BrdU-Positive and TUNEL-Positive Cells per 50 HPFs Restricted to Renal Cortical Histological Compartments
Periglomerular* Tubular Interstitial
Tubulointerstitial
macrophage correlation†
BrdU r  0.47, P  0.01
Depletion 	 64  4.6 497  79 502  39
Depletion  10  7.6§ 198  8§ 193  28§
TUNEL r  0.47, P  0.01
Depletion 	 47  12 387  94 356  44
Depletion  17  0.7§ 221  26‡ 213  10§
*Per 50 glomeruli.
†Correlation between the number of BrdU-positive or TUNEL-positive tubulointerstitial cells and the area of macrophage staining.
Mean  SEM. ‡P  0.05 and §P  0.01 compared with macrophage-depleted mice.
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of interstitial macrophages that were proliferating, tissue
sections were stained for the macrophage marker F4/80
and nuclear BrdU incorporation. In control-treated, dis-
eased mice, 12.3 1.6% of BrdU-positive interstitial cells
were macrophages, representing 0.19  0.13% of all
macrophages. These results indicate that although mac-
rophages can proliferate in the kidney, they represent
relatively few proliferating interstitial cells, and therefore
interstitial myofibroblasts are the major proliferating cell
population in the injured interstitium. Thus, macrophages
regulate proliferation of both tubular cells and interstitial
cells, either directly or by indirect mechanisms.
Apoptosis was assessed in sections adjacent to sec-
tions used for BrdU staining. In the glomerulus the num-
ber of TdT uridine nick-end labeled (TUNEL)-positive
cells (a marker of apoptosis) was similar in diseased mice
irrespective of macrophage depletion (Figure 7, A and
B). In the rest of the cortex, however, the number of
TUNEL-positive cells was significantly reduced by mac-
rophage depletion (Figure 7B, Table 1). Analysis of
TUNEL-positive cells in separate tubular and interstitial
compartments indicated that macrophage depletion was
associated with reduced levels of tubular cell and inter-
stitial cell apoptosis. Apoptosis of periglomerular cells
was also decreased (Table 1). A significant correlation
was evident between the area of cortical staining for
macrophages and the number of TUNEL-positive cells in
each mouse (Table 1) thereby providing further evidence
for a link between macrophage infiltration and both tubu-
lar and interstitial cell death.
Recruitment of CD4 T Lymphocytes Is
Diminished after Macrophage Depletion
We have previously reported this model of nephrotoxic
nephritis to be dependent on activated CD4 T lympho-
cytes.38 In some settings activated T-lymphocytes can
activate monocytes/macrophages by both contact-de-
pendent and paracrine mechanisms. For example, pro-
duction of interferon- by activated CD4  TH1 lympho-
cytes may contribute to macrophage activation.39 We
now provide evidence that inflammatory macrophages in
the kidney are partly responsible for the recruitment of
lymphocytes to the kidney. The effect of intravenous DT
injection on circulating T cells in the DTR mice was as-
sessed by CD3 immunolabeling. Twenty-four hours after
administration of DT, whole blood leukocytes were la-
beled with anti-CD3 antibodies. Simultaneously mono-
cytes and neutrophils were assessed using CD11b and
F4/80 antibodies and anti-GR-1 antibodies, respectively
(Table 2). The number of circulating T cells was not
Figure 7. Tubulointerstitial apoptosis is reduced by macrophage ablation. A: Immunostaining for apoptotic nuclei using the TUNEL method (400). Note
interstitial apoptosis (arrowhead) and tubular cell apoptosis (arrows) in diseased mice (left) and a reduction in tubulointerstitial apoptosis after macrophage
depletion (right). B: The number of intraglomerular apoptotic cells per 50 glomerular cross sections in CD11b-DTR diseased mice treated with PBS or DT. C: The
number of tubulointerstitial apoptotic cells per 50 HPF in CD11b-DTR diseased mice treated with PBS or DT (*P  0.05).
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significantly different in DT-treated DTR mice compared
with PBS-treated DTR mice. By comparison the monocyte
population was depleted by 80% (Table 2). These data
are in accordance with our previous work.25 The number
of T lymphocytes in the nephritic kidneys at day 20 of
disease was assessed by immunostaining for CD4- and
CD8-expressing cells. Compared with macrophages
there were very few lymphocytes in both the interstitium
and glomeruli (Table 2). The frequency of T cells was
sufficiently low that greater accuracy was obtained by
counting individual cells per HPF rather than by mor-
phometry. The number of CD4 T cells was reduced in
both the glomerular and interstitial compartments of the
kidney after macrophage depletion (Table 2). The num-
ber of CD8 T cells was not reduced in nephritic kidneys
of mice that underwent macrophage depletion. These
results indicate that macrophages are likely to play an
important role in the recruitment, or possibly survival, of
CD4 T cells to the kidney and may represent an addi-
tional mechanism by which macrophage depletion halts
progression of crescentic GN.
Depletion of Macrophages Alters the Balance of
Enzymes Regulating Matrix Turnover and the
Balance of Inflammatory Cytokines
To understand the molecular mechanisms by which in-
flammatory macrophages mediate the effects we have
described, we measured the transcript levels in whole
kidney of several candidate genes that might be modu-
lated by macrophage depletion (Table 3). Although none
of the candidate genes are exclusively expressed by
macrophages, these genes are believed to play impor-
tant roles in disease such as modulation of inflammatory
processes, induction of cell death, and the deposition
and degradation of matrix. Importantly, we did not iden-
tify any difference in the levels of tnf or tgf1 transcript
in diseased kidneys after macrophage depletion. Trans-
forming growth factor- is widely expressed in both pa-
renchymal cells of the kidney and inflammatory cells
during disease.31 Further, tgf1 transcript levels have
been reported not to correlate well with protein levels or
cytokine activity.40 Tumor necrosis factor- may also be
expressed by parenchymal cells of the kidney.41 These
observations may explain why transcript levels did not
differ in our study. It is of interest that, although il-10
transcript is generated at lower levels than tnf, macro-
phage depletion resulted in a greater than sevenfold
increase in il-10 transcript expression. Interleukin-10 may
be generated by macrophages as well as TH2 cells and
is a potent anti-inflammatory cytokine.42 In addition we
determined transcript levels for two major factors govern-
ing matrix turnover, mmp-13 (collagenase 1) and timp-1.
Although transcript levels of the major mouse collage-
nase, mmp-13, decreased approximately fourfold after
macrophage depletion, transcript of its inhibitor TIMP-1
decreased fivefold. TIMP-1 is a potent inhibitor of MMP
activity such that there may be no collagenase activity in
the presence of TIMP-1 expression even when tissue
levels of MMP-13 are high.43 Therefore these data sug-
gest that regulation of TIMP-1 might represent a mecha-
nism by which macrophage depletion ameliorates tissue
fibrosis.
Discussion
In a murine model of severe crescentic GN we have
successfully depleted macrophages from the renal cor-
tex for 5 consecutive days during established progres-
sive disease. Importantly, macrophage depletion had no
effect on the amount of circulating anti-sheep immuno-
globulin compared to control diseased mice (data not
Table 2. Circulating Leukocytes 24 Hours after Administration of DT to CD11b-DTR and Renal T Cells at Day 20 of Nephrotoxic
Nephritis with and without Macrophage Depletion
CD3 CD4 CD8 Gr-1 F4/80
Blood*
Depletion 	 2042  644 511  59 261  31
Depletion  2226  1061 487  63 59  8¶
Kidney
Depletion 	 13.3  1.1† 3.3  1.2
Depletion  6.3  2.2§ 2.0  1.1
Glomerulus‡
Depletion 	 12.7  2.4 0.4  0.4
Depletion  6.0  3.0§ 0.8  0.7
*Peripheral blood leukocyte counts expressed as cells (1000) per ml of whole blood.
†Cortical kidney T-cell counts expressed as cells per high-power field.
‡Glomerular T-cell counts expressed as cells per 50 glomerular cross sections.
Mean  SEM. §P  0.05 and ¶P  0.01 compared with macrophage-depleted mice.
Table 3. The Effect of Macrophage Depletion on Cytokine Message Levels within the Kidney
TNF- TGF- IL-10 TIMP-1 MMP-13
Depletion 	 1.36  0.75 19.4  6.6 0.046  0.011* 0.0114  0.0061* 0.0039  0.0021*
Depletion  1.62  0.51 16.0  3.4 0.365  0.118 0.0029  0.0011 0.00079  0.00028
*P  0.05 relative to depletion. All values are relative to GAPDH.
1216 Duffield et al
AJP November 2005, Vol. 167, No. 5
shown) indicating that the effects seen were directly re-
lated to macrophage depletion in the kidney. Histological
and functional parameters demonstrate that macro-
phages are important mediators of disease progression
and play a dominant role in the pathology of both glo-
merular crescents and tubulointerstitial inflammation and
scarring.
A key finding of this study is that macrophage-de-
pleted mice exhibited improved renal function and re-
duced levels of proteinuria indicating that the overall
effect of macrophage infiltration is functionally detrimen-
tal in this model of progressive renal inflammation. Fur-
thermore, although this model of renal inflammation is
characterized by progressive disease between day 15
and day 20, histological analysis revealed a marked re-
duction in renal injury and fibrotic scarring after macro-
phage depletion. Our observations therefore suggest that
macrophages represent a potential target for therapeutic
intervention.
Our study has identified some of the mechanisms by
which inflammatory macrophages mediate deleterious
effects. Firstly, they target tubular epithelial cells such
that macrophage depletion protects this tissue compart-
ment from both injury and apoptotic cell death and the
resultant histological changes of tubular atrophy and in-
creased tubular luminal space. We and others have
shown that morphometric measurement of tubular luminal
space provides an objective measurement of tubular in-
jury. Elevated tubular luminal space correlates with a
poor renal prognosis in human nephritis.28 Interestingly,
interstitial macrophages may also trigger tubular cells
into the cell cycle as evidenced by the significant reduc-
tion in both BrdU incorporation and PCNA expression
after macrophage depletion. Secondly, macrophages
target the myofibroblast populations of the interstitium
and the periglomerular crescents. Macrophages may
also trigger myofibroblasts to enter the cell cycle or un-
dergo apoptosis. However, unlike tubular epithelial cells,
the overall effect on the myofibroblast population is sup-
portive. Whereas tubular cells are injured and are pro-
gressively lost, myofibroblasts survive and in the pres-
ence of macrophages the myofibroblast population
undergoes net expansion. Thirdly, the deposition of inter-
stitial collagens, associated with long-term scarring and a
poor functional outcome, is also dependent on inflamma-
tory macrophage infiltration.
A close relationship between the degree of inflamma-
tory macrophage infiltration and tubular epithelial cell
apoptosis has been reported in two recent studies.8,44
Indeed, it has been proposed that macrophages might
actively induce tubular cell apoptosis in both murine
nephrotoxic nephritis and a murine model of Alport’s
GN.45,46 Our findings would be in keeping with those
observations. The fact that we actively and specifically
depleted macrophages for the first time during kidney
injury provides strong evidence that the correlations be-
tween epithelial cell death and macrophages previously
reported are direct cause and effect.
We also report here that tubular cell proliferation was
increased in the presence of macrophages. One inter-
pretation of such findings is that macrophages not only
trigger epithelial cells into cell cycle but they simulta-
neously trigger apoptosis. Selective killing of cells at
checkpoints in the cell cycle has been recognized in
tumor cell biology, inflammation, and development.3,47,48
Indeed we have previously demonstrated that macro-
phages in the developing eye trigger cell cycle-depen-
dent death of endothelial cells. In this scenario, macro-
phages trigger cells from G0 into G1, then by a second
mechanism activate the apoptotic machinery at the G1
cell-cycle checkpoint. It is plausible that inflammatory
macrophages test tubular epithelial cell health, because
there will be a delay at the G1 checkpoint when cells
enter the cell cycle if problems exist in the synthetic
process. At this stage of the cell cycle, cells exhibit an
enhanced susceptibility to proapoptotic stimuli that may
be generated by inflammatory macrophages.
Our data suggest that macrophages mediate much of
their deleterious effect in progressive renal inflammation by
regulating the population of myofibroblasts both in the cres-
cent and in the interstitium. Our data show that the popula-
tions of myofibroblasts are expanded in the presence of
inflammatory macrophages. Furthermore, collagen III, a
synthetic product of myofibroblasts and a component of
interstitial fibrosis is deposited in greater quantities in the
presence of macrophages. In vitro studies of the interaction
between macrophages and myofibroblasts provide evi-
dence that macrophages are capable of inducingmyofibro-
blast proliferation,49–51 apoptosis, abnormal cell matrix syn-
thesis, and cell matrix degradation through production of
nitric oxide, tumor necrosis factor-, and up-regulation of
collagenases and other metalloproteinases.6 Our data also
indicate that fibroblasts in the presence of macrophages
are undergoing both cell proliferation and apoptosis. It is
therefore likely that macrophages are also triggering fibro-
blasts to both proliferate and undergo apoptotic cell death.
We have previously reported that classically activated mac-
rophages induce cell death in proliferating mesangial myo-
fibroblast cells in vitro.4,5 This death is targeted to the G1 to
S phase of the cell cycle such that the greater the rate of
proliferation, the greater the rate of macrophage-directed
killing of mesangial cells. However, in vivo in the kidney, and
unlike conditions for epithelial cells, the conditions favor
successful proliferation, rather than excessive cell death,
thereby resulting in an expanded myofibroblast population.
In keeping with an expanded population of myofibroblasts,
the deposition of collagen III is also increased in the pres-
ence of macrophages. Although increased deposition of
matrix collagens might simply be a reflection of an in-
creased population of myofibroblasts, in vitro studies indi-
cate that myofibroblasts can result in a net loss of matrix
collagens by expressing matrix metalloproteinases pre-
dominantly, or failing to express inhibitors of matrix metal-
loproteinases (TIMPs). Our study shows that whole kidney
transcripts for both the major collagenase MMP-13 and its
inhibitor TIMP-1 are decreased by macrophage depletion.
Because TIMP-1 expression inhibits MMP activity potently
one interpretation of these data are that MMP activity will
rise after macrophage depletion due to down-regulation of
TIMP-1. Thus one mechanism by which collagen III is re-
duced after macrophage depletion may be by down-regu-
lation of TIMP-1. Both these data and the in vitro studies
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suggest15,16 that in addition to macrophage-myofibroblast
cross talk in terms of cell cycle and cell death, macro-
phages also signal myofibroblasts to lay down matrix rather
than remove it through activation of degradative enzymes.
Inflammatory macrophages in the kidney have been re-
ported to proliferate.37,52 Our data are in broad agreement
with this finding. The proportion of macrophages that are
actively proliferating is however low compared with tubular
cells and myofibroblasts, and is comparable with recent
reports of macrophage proliferation in mouse kidney tubu-
litis observed during transplant rejection.37 In a rat model of
GN as many as 62% of macrophages were reported to be
proliferating,52 and far exceeds the findings of this study.
Whether this reflects differences between rat and mouse
disease models, or disparity between PCNA-positive immu-
nostaining (as reported in the rat model) and BrdU incor-
poration remains to be determined.
Although the number of T cells in the kidney was low
compared with inflammatory macrophages, intrarenal
CD4 T cells were reduced by macrophage depletion. Our
DTR model has no effect on the number of circulating T
cells. It is likely therefore that macrophages either contribute
to the recruitment or survival of CD4 cells in the kidney.
Thus another mechanism by which macrophages contrib-
ute to the pathogenesis of crescentic GN is through main-
taining a population of CD4 T cells. We have recently
demonstrated a pivotal role for resident peritoneal macro-
phages in recruiting neutrophils to the inflamed peritoneal
cavity by release of the neutrophil chemokines MIP-2 and
KC.25 Macrophages express MIP-1 and MIP-1, potent
ligands for CCR5 that is the dominant chemokine receptor
for CD4 TH1 cells.
53 CD8 cells recruited to the kidney
may rely more heavily on other receptors such as CCR1 or
possibly CCR3, whose ligands include RANTES and
eotaxin, chemokines expressed by many cells in the kidney
including tubular cells.54–56 It is possible therefore that the
selective reduction in CD4 cells over CD8 cells reflects a
reduction of macrophage-derived chemokines. In our study
the transcript for il-10 is increased after macrophage deple-
tion. Further studies will be required to identify the source of
interleukin-10, but one candidate is a population of TH2
cells. It is tempting to suggest that because TH2 CD4
 cells
represent a potent source of interleukin-10 and because
they express different chemokine receptors (CCR4 and
CCR8) from TH1 cells, macrophage depletion selectively
reduces recruitment or differentiation of TH1 cells but not
TH2 cells.
57 Further studies will be required to dissect the
mechanisms by which macrophages regulate T-cell
recruitment.
The transgenic DTR conditional macrophage ablation
system offers the possibility of dissecting the chronological
role of macrophages in inflammation in more detail. It has
been proposed that distinct functional subsets of macro-
phages exist within inflamed sites. One extreme of this
dichotomy, the classically activated macrophage, would be
expected to mediate tissue destruction and cell death,
whereas the other extreme phenotype, the alternatively ac-
tivated macrophage might be expected to promote cell
proliferation, debridement of damaged tissue, and synthe-
sis of new matrix.6,58 Our data in nephrotoxic nephritis sug-
gest that the in vivo situation is complicated because the
infiltrating macrophage population appears to exhibit fea-
tures of both subsets, ie, induction of cell death together
with promoting cell proliferation. It might be that performing
macrophage depletion at different time points in disease
and subsequent recovery may well reveal functionally dis-
tinct macrophage subtypes as we have recently demon-
strated in the liver.24 Our work suggests that macrophages
play a key role in determining the functional and patholog-
ical outcome of disease in an experimental model of glo-
merular and tubulointerstitial inflammation that has analo-
gies with progressive human disease and that infiltrating
macrophages may well merit specific targeting in human
disease.
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